SUMMARY -Schwannomas are benign encapsulated tumors arising from the sheaths of peripheral nerves. Th ey present as slowly enlarging solitary lumps, which may cause neurological defects. Multiple schwannomas in non-neurofi bromatosis type 2 patients are extremely rare. We report a case of a 60-year-old female patient, without any family history of neurofi bromatosis or schwannomatosis, presented with trigeminal neuralgia and progressive facial nerve palsy. Magnetic resonance imaging revealed the presence of acoustic schwannoma involving facial nerve and trigeminal schwannoma of the cisternal part of the nerve involving gasserian ganglion (Meckel's cave). After gamma knife radiosurgery, trigeminal neuralgia was relieved completely with improvement of facial nerve palsy.
Introduction
Schwannomas (neurilemmomas) are benign, slowgrowing, encapsulated tumors originating from Schwann cells that form myelin sheath around peripheral, cranial, and autonomic nervous systems. Th ey develop on the outside of the nerve, but may push it aside or against adjacent structures causing damage 1 . Schwannomas account for 7% of all intracranial tumors 2 , and among them vestibular schwannomas are most common. However, those originating from the trigeminal ganglion or nerve root, or other cranial nerves are considered rare 1 . We report a case of schwannomas of the vestibular and trigeminal nerves in a non-neurofi bromatosis type 2 (NF2) female patient who presented with trigeminal neuralgia and progressive facial nerve palsy.
Case Report
A 60-year-old female was admitted to the Clinical Department of Neurology, Split University Hospital Center, because of acute right-side facial palsy (HouseBrackmann grade IV). She did not complain of any episode of vertigo, dizziness, or tinnitus. Th e basic laboratory tests (peripheral blood and blood chemistry fi ndings) were within the normal limits.
Her medical history showed that she also had suffered from right-sided infranuclear facial palsy (House-Brackmann grade III) a year before. Otherwise, she was healthy and no other focal neurological signs or symptoms including hearing disturbances were elicited at that time. She was administered 20 mg prednisone per day for 5 days, including gastric and local eye protection therapy. Prednisone was discontinued by gradual reduction of dosage. After physiotherapy, facial function improved gradually to grade II. Six months later, she presented with right trigeminal neuralgia. Th e pain aff ected initially the maxillary and then the ophthalmic divisions of the trigeminal nerve, characterized as sharp and lancinating pain of moder-ate to severe intensity. Systemic and neurological examinations were normal. In particular, trigeminal sensation was intact bilaterally and trigeminal refl exes were normal. Conventional analgesia in high dosage relieved pain. Based on her positive medical history of neuralgia, magnetic resonance imaging (MRI) of the brain was performed to reveal the presence of rightside trigeminal and vestibular nerve schwannomas also involving the ganglion segment of the facial nerve (Fig. 1) .
Ophthalmologic and general physical examinations did not reveal any fi ndings suggestive of neurofibromatosis. Th ere was no family history of neurologic disturbances, café-au-lait spots, tumors of the skin or central nervous system. Th e patient underwent gamma knife radiosurgery for trigeminal schwannoma and vestibular schwannoma. An obvious decrease in tumor volumes was observed. Trigeminal neuralgia was relieved completely with improvement of facial nerve palsy (House-Brackmann grade II) during 9-month clinical follow up.
Discussion
Vestibular schwannomas are the most common intracranial site of schwannoma occurrence. Th ey comprise 90% of all cranial nerve schwannomas, followed by the second most common but much rarer trigeminal schwannomas 1 . Cranial nerve schwannomas usually manifest sporadically as a single neoplasm. Th e presence of multiple schwannomas in the same patient suggests tumorigenesis and a possible association with NF2 or schwannomatosis 3, 4 . Only 3% of the schwannoma patients have multiple schwannomas in association with NF2, and 2% have schwannomatosis without NF2 4 . Th e National Institutes of Health criteria 5 are probably the most reliable diagnostic criteria for NF2. Th ese criteria have been expanded 6 to also include patients with unilateral acoustic schwanoma, and two of the following: meningioma, glioma, neurofi broma, schwannoma, or posterior subcapsular lenticular opacity. Our patient did not fulfi ll diagnostic criteria for NF2. Except for those two schwannomas, she did not reveal any other fi ndings suggestive of NF2, and what is also important for diagnosis, her family history was negative for neurofi bromatosis.
Schwannomatosis is the third major form of neurofi bromatosis. Geneticists, neurologists, and pathologists have recognized that schwannomatosis is distinct from NF2. It is characterized by the presence of two or more non-intradermal schwannomas, including no bilateral vestibular schwannomas. Some schwannomatosis patients have been reported to have unilateral vestibular schwannoma 7 . According to these criteria, our patient could probably be classifi ed under this diagnosis.
Kambe et al. 8 report on the same case of multiple schwannomas in a non-NF2 patient. Th e patient, without any family history of neurofi bromatosis, presented with two separate schwannomas, trigeminal schwannoma and vestibular schwannoma. Like our patient, this patient did not reveal any other fi ndings suggestive of NF2 either, but molecular genetic analysis detected genetic alterations of the NF2 gene.
It is not always easy, on the basis of the clinical picture, to classify patients as NF2 or schwannomatosis, especially those patients with unilateral vestibular schwannoma. However, according to Aghi et al., who have described clinical features of unique phenotypeunilateral vestibular schwannoma with other NF2-related tumors, patients with this phenotype should undergo evaluation and monitoring similar to that conducted in patients with NF2, and the possibility of aggressive contralateral vestibular schwannoma formation should also be considered in their clinical evaluation 9 . Following the diagnosis, and taking into account the patient's age and locations of tumors, gamma knife radiosurgery was considered therapy of choice in the present case. Long-term follow up demonstrated gamma knife radiosurgery to off er a high rate of tumor control, preservation of multiple nerve functions, and good quality of life in patients with both vestibular schwannoma and trigeminal schwannoma 10, 11 . Th e presented case is unique because it shows a rare phenotype of multiple schwannomas (unilateral vestibular schwannoma and trigeminal schwannoma) in a non-NF2 patient with no other stigmata of neurofibromatosis.
It also shows that progressive facial palsy without any disturbances of hearing is probably not Bell's palsy. In patients with such symptoms, especially if they have recurrent facial palsy and other neurological signs, it is important to examine other rare causes.
